India emerges as new drug trial hot spot

India emerges as new drug trial hot spot
Biotech entrepreneurs see Indian clinical trials � which can cut costs by 60 percent � as the difference between success and slow death.


Leave a Reply

Your email address will not be published. Required fields are marked *